Safira’s Senior Director of Social Media & Digital Excellence, Michael Durwin, is slated to deliver a keynote address at the upcoming eClinical Forum Autumn Workshop, scheduled for October 24-26 at the Janssen Research and Development headquarters in Spring House, Pennsylvania. Durwin’s talk will delve into the burgeoning landscape of LLMs (Large Language Models) and their profound influence on clinical trials. Additionally, he will provide an insightful overview of Social Intelligence and its multifaceted advantages within the realm of clinical trials and the pharmaceutical industry. Durwin is a 27-year veteran of social media strategy and has been working with LLMs, Artificial Intelligence (AI) and Natural Language Processing (NLPs) for over a decade.
Other topics being discussed during the workshop include:
- The role of GDPR / Data Privacy in clinical research
- Topics in AI and Emerging Technologies
- EMA Guideline on computerised systems and electronic data in clinical trials – Implications
- Round-table discussions: Decentralised elements, e-Informed Consent, Data Flow
- Sustainability: Climate Footprint of clinical trials
Learn more about the eClinical Forum Autumn Workshop here: https://eclinicalforum.org/news/eclinical-forum-autumn-workshop-spring-house-pennsylvania.
Learn more about Safira’s Social Intelligence services here: https://safiracr.com/social-intelligence.